Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-08-001497
Filing Date
2008-03-18
Accepted
2008-03-17 21:54:32
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c72695e10vk.htm 10-K 1300780
2 EXHIBIT 31.1 c72695exv31w1.htm EX-31.1 6796
3 EXHIBIT 31.2 c72695exv31w2.htm EX-31.2 6767
4 EXHIBIT 32.1 c72695exv32w1.htm EX-32.1 4725
5 GRAPHIC c72695c7269501.gif GRAPHIC 8077
  Complete submission text file 0001362310-08-001497.txt   1331756
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 6506241000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 08694774
SIC: 2834 Pharmaceutical Preparations